Concord Drugs Unveils ₹188.7 Mn Capital Infusion Plan via Warrants & Equity Issue

Unknown Apr 02, 2026 1,200 Views

Concord Drugs Ltd has announced a dual capital-raising initiative totaling ₹188.7 million, aimed at strengthening its balance sheet and funding future growth. The board has approved the issuance of 2 million convertible warrants and 3.2 million equity shares, both priced at ₹36.30 per unit. &...